Maximum: 1 CME cr.,
1 AutoAttendance cr.
Sign in to view your progression
Program Overview Progr...
Learning Objectives Learn...
Target Audience Targe...
References Refer...
Disclosure/Disclaimer Discl...

Activity Title: COVID-19 Vaccines: Trust, Transparency and Global Access

Release Date: February 2, 2021

Estimated Time to Complete Activity: 70 minutes

Statement of Need:

The development of accepted vaccines that are available on a global scale is a priority to end the COVID-19 pandemic. Recently, there have been dramatic shifts in vaccine confidence around the world that threaten the success of approved COVID-19 vaccines as well as the likelihood of achieving herd immunity. This webinar will discuss the current state of COVID-19 vaccine confidence in Latin America, reasons for hesitancy, and will propose ways forward. The need for COVID-19 vaccines is global, although the need is differentially distributed within populations. High income countries must not monopolize the global supply and every effort must be made to provide vaccines at a price affordable to low- and middle-income countries. Understanding the complexities of establishing a regionally and globally fair vaccine-allocation system are essential.

Faculty:

Heidi J. Larson, PhD, is Professor of Anthropology, Risk and Decision Science and is the Founding Director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine. She is also Clinical Professor of Health Metrics Sciences, University of Washington, Seattle, USA, and Guest Professor at the University of Antwerp, Belgium.

Professor Gagandeep Kang is a physician scientist who for many years was a Professor of Microbiology and Head of the Division of Gastrointestinal Sciences and the Wellcome Trust Research Laboratory at the Christian Medical College (CMC), Vellore. She holds MBBS, MD and PhD degrees from CMC and a Fellowship of the Royal College of Pathologists, London

Technical Requirements

This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers. For interactive content a broadband connection is required. For CME/CE activities featuring audio you need a sound card and speakers.

Our activities may require JavaScript to be enabled on your computer. If you are having difficulty viewing pop-up windows, click here for instructions on enabling JavaScript.

Contact Information

If you have questions about this CME activity, please contact The International Society for Infectious Diseases at info@isid.org.

For technical support issues, please contact Multilearning at support@multilearning.com

Supported by an Unrestricted Educational Grant from Pfizer Global Medical Grants

Upon completion of this module, participants should be able to:

  • Discuss the recent shifts in vaccine confidence around the world that threaten the success of approved COVID-19 vaccines as well as the likelihood of achieving herd immunity
  • Understand the reasons for this confidence shift
  • Discuss the current state of COVID-19 vaccine confidence in Latin America, reasons for hesitancy, and  proposed ways forward
  • Recognize the issues associated with the differentially distributed vaccinations within populations across the globe and understand the complexities of establishing a regionally and globally fair vaccine-allocation system
  • Discuss why high income countries must not monopolize the vaccine global supply and why every effort must be made to provide vaccines at a price affordable to low- and middle-income countries. 

The target audience for this module is physicians, nurses, public health officials, researchers, immunization officers, and other health professionals.

The Coalition for Epidemic Preparedness Innovations (CEPI): New vaccines for a safer world: https://cepi.net

COVAX: Working for global equitable access to COVID-19 vaccines. https://www.who.int/initiatives/act-accelerator/covax

Hotez P, Batista C, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Strub-Wourgaft N, Yadav P, Bottazzi ME. Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. EClinicalMedicine. 2021 Mar;33:100780. doi: 10.1016/j.eclinm.2021.100780. Epub 2021 Mar 6. https://www.nature.com/articles/s41541-021-00323-6

Burgess RA, Osborne RH, Yongabi KA, Greenhalgh T, Gurdasani D, Kang G, Falade AG, Odone A, Busse R, Martin-Moreno JM, Reicher S, McKee M. The COVID-19 vaccines rush: participatory community engagement matters more than ever. Lancet. 2021 Jan 2;397(10268):8-10. doi: 10.1016/S0140-6736(20)32642-8. Epub 2020 Dec 10. PMID: 33308484; PMCID: PMC7832461. https://pubmed.ncbi.nlm.nih.gov/33308484/

Larson HJ, Broniatowski DA. Volatility of vaccine confidence. Science. 2021 Mar 26;371(6536):1289. doi: 10.1126/science.abi6488. PMID: 33766861. https://pubmed.ncbi.nlm.nih.gov/33766861/

Acharya, K.P., Ghimire, T.R. & Subramanya, S.H. Access to and equitable distribution of COVID-19 vaccine in low-income countries. npj Vaccines 6, 54 (2021). https://doi.org/10.1038/s41541-021-00323-6

Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines (Basel). 2021 Feb 16;9(2):160. doi: 10.3390/vaccines9020160. PMID: 33669441; PMCID: PMC7920465.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920465/

London School of Hygiene & Tropical Medicine: The Vaccine Confidence Project. https://www.vaccineconfidence.org

US Centers for Disease Control: COVID-19 Vaccination Communication Toolkit to promote vaccine confidence among Healthcare Providers. https://www.cdc.gov/vaccines/covid-19/health-systems-communication-toolkit.html

Supported by an Unrestricted Educational Grant from Pfizer Global Medical Grants

Disclosure Policy

In accordance with the EACCME Standards for Commercial Support, the International Society for Infectious Diseases (ISID) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ISID  resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all our educational programs. Furthermore, ISID seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ISID is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures:

The planners, reviewers, editors, staff, or other members at the International Society for Infectious Diseases who control content have no relevant financial relationships to disclose. 

ISID Knowledge Exchange and E-Learning Platform Organizing Committee members are listed here along with Committee members’ disclosure forms. 

Faculty Disclosures:

Professor Gagandeep Kang has no actual or potential conflict of interest in relation to this program/presentation.

Professor Heidi  Larson
Affiliation/Financial Interest and Name of Commercial Company:
Grants/Research Support: GSK, J&J, Merck
Honoraria or Consultation Fees: GSK, Merck

Moderator Disclosures:

Professor Paul Anantharajah Tambyah
Grants/Research Support: Roche, Arcturus, Johnson and Johnson

Disclosure of Unlabeled Use

The International Society for Infectious Diseases  requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ISID does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The International Society for Infectious Diseases presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The International Society for Infectious Diseases, and the former commercial supporter assume no liability for the information herein.

Copyright Information

Copyright © 2021 by the International Society for Infectious Diseases. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

•  The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

•  Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without the International Society for Infectious Diseases' prior written permission.

Privacy Policy

The International Society for Infectious Diseases protects the privacy of personal and other information regarding participants and educational collaborators. The International Society for Infectious Diseases will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The International Society for Infectious Diseases maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding the International Society for Infectious Diseases Privacy Policy and ISID’s Knowledge Exchange and E-Learning Platform Privacy Policy can be viewed at https://isid.org/privacy-policy/ and https://exchange.isid.org/isid/legal/terms-and-conditions.

 

COVID-19 Vaccines: Trust, Transparency and Global Access

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies